The DCT gene is highly expressed in chemo- and radiotherapy-resistant mouse/human melanoma cells that undergo de-differentiation and thus can be used as a marker in complement of GP100 for melanoma detection and staging [24,25,26]. The gene discussed is PMEL; the disease is melanoma.